Depressive Disorder  >>  olanzapine/fluoxetine  >>  Phase 4
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
olanzapine/fluoxetine / Generic mfg.
NCT00188942: A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar Disorder

Completed
4
42
Canada
Fluoxetine+Olanzapine, Olanzapine, Functional Magnetic Resonance Imaging
University Health Network, Toronto, Eli Lilly and Company
Major Depressive Disorder
06/09
06/09
NCT00844857: A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression

Completed
4
291
US, RoW
Olanzapine Fluoxetine Combination (OFC), LY900000, Symbyax, Placebo
Eli Lilly and Company
Bipolar Depression
02/12
02/12
NCT01833897: NMDA Antagonists in Bipolar Depression

Completed
4
8
US
Standard of Care, Quetiapine, Olanzapine, fluoxetine, Ketamine, Ketamine Hydrochloride, D-cycloserine, DCS
New York State Psychiatric Institute
Bipolar Disorder
07/14
03/16

Download Options